RALCEPA
Table of contents:
| Trademark domain | |
| name | is free? |
|---|---|
| ralcepa.com |  |
The "RALCEPA" trademark, serial number 78656824 , was filed on 23rd of June 2005 with a mark drawing code of 4000 and its transaction date is 78656824. The attorney assigned is Nadine P. Flynn, attorney docket number . Since 31st of December 2009, the document can be found in the L30 law office in the publication and issue section. The employee responsible is GRIFFIN, JAMES and the date it was published for opposition on 08/01/2006. The status of this trademark was checked last on 11/23/2009.
Other trademarks by this attorney include , ACUBILITY , ERZELBA , ACOMOTAT . The corresponded responsible for this trademark is Nadine P. Flynn, located at BRISTOL-MYERS SQUIBB COMPANY, Trademark Department, 345 PARK AVE.The state or country where the trademark was organized is NY by Bristol-myers Squibb Company. The legal entity type behing it is a Corporation, located at 345 Park Avenue, New York, NY zip 10154.Other trademarks by this applicant: DARCELBA.
| GOODS AND/OR SERVICES | |
| International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
|---|---|
| U.S. Class | 052 - Detergents and Soaps |
| Class Status | 6 - Active |
| Status Date | 06/28/2005 |
| Primary Code | 005 |
| Goods codes | |
| GS0051 | Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, and pharmaceutical antibodies; diagnostic pharmaceutical preparations for human use for increasing the heart rate and contrast imaging agents |
| PROSECUTION HISTORY | ||||
| Date | Description | Type | Code | |
|---|---|---|---|---|
| 11/23/2009 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | O - Outgoing Correspondence | MAB6 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | |
| 11/23/2009 | ABANDONMENT - NO USE STATEMENT FILED | S | ABN6 - ABANDONMENT - NO USE STATEMENT FILED | |
| 05/05/2006 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 04/03/2009 | EXTENSION 5 GRANTED | S | EX5G - EXTENSION 5 GRANTED | |
| 03/16/2009 | EXTENSION 5 FILED | S | EXT5 - EXTENSION 5 FILED | |
| 04/03/2009 | CASE ASSIGNED TO INTENT TO USE PARALEGAL | A - Allowance for Publication | AITU | |
| 03/16/2009 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 09/28/2008 | EXTENSION 4 GRANTED | S | EX4G - EXTENSION 4 GRANTED | |
| 09/28/2008 | EXTENSION 4 FILED | S | EXT4 - EXTENSION 4 FILED | |
| 09/28/2008 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 03/24/2008 | EXTENSION 3 GRANTED | S | EX3G - EXTENSION 3 GRANTED | |
| 03/24/2008 | EXTENSION 3 FILED | S | EXT3 - EXTENSION 3 FILED | |
| 03/24/2008 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 09/19/2007 | EXTENSION 2 GRANTED | S | EX2G - EXTENSION 2 GRANTED | |
| 09/19/2007 | EXTENSION 2 FILED | S | EXT2 - EXTENSION 2 FILED | |
| 09/19/2007 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 04/02/2007 | EXTENSION 1 GRANTED | S | EX1G - EXTENSION 1 GRANTED | |
| 04/02/2007 | EXTENSION 1 FILED | S | EXT1 - EXTENSION 1 FILED | |
| 04/02/2007 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 10/24/2006 | NOA MAILED - SOU REQUIRED FROM APPLICANT | O - Outgoing Correspondence | NOAM - NOTICE OF ALLOWANCE-MAILED | |
| 08/01/2006 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
| 07/12/2006 | NOTICE OF PUBLICATION | O - Outgoing Correspondence | NPUB - NOTICE OF PUBLICATION | |
| 06/16/2006 | LAW OFFICE PUBLICATION REVIEW COMPLETED | O - Outgoing Correspondence | PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED | |
| 06/09/2006 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
| 06/02/2006 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
| 05/31/2006 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
| 05/15/2006 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 05/05/2006 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 01/17/2006 | NON-FINAL ACTION MAILED | F - First Action | CNRT - NON-FINAL ACTION MAILED | |
| 01/16/2006 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 01/14/2006 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
| 06/28/2005 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM | |
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.